SC
IONS icon

SouthState Corp’s Ionis Pharmaceuticals IONS Stock Holding History

SouthState Corp’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11K Hold
14
– – ﹤0.01% 1090
2026
Q1 		$1.05K Hold
14
– – ﹤0.01% 1036
2025
Q4 		$1.11K Sell
14
-19
-58% -$1.43K ﹤0.01% 1097
2025
Q3 		$2.16K Sell
33
-18
-35% -$879 ﹤0.01% 919
2025
Q2 		$2.02K Sell
51
-68
-57% -$2.23K ﹤0.01% 1092
2025
Q1 		$3.59K Buy
+119
New +$3.9K ﹤0.01% 1053

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

SouthState Corp's IONS Position: Q2 2026 in Review

SouthState Corp held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 14 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #1090.

SouthState Corp first reported a position in IONS in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.59K in Q1 2025. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • SouthState Corp held 14 shares of Ionis Pharmaceuticals worth $1.11K as of Q2 2026.
  • SouthState Corp left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #1090 holding.
  • SouthState Corp first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • SouthState Corp's Ionis Pharmaceuticals position peaked at $3.59K in Q1 2025.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.